NCT00490204View on ClinicalTrials.gov

Cetirizine Placebo Controlled Study For Perennial Allergic Rhinitis

PHASE3CompletedINTERVENTIONAL
Enrollment

239

Participants

Timeline

Start Date

July 27, 2007

Primary Completion Date

October 3, 2007

Study Completion Date

October 3, 2007

Conditions
Rhinitis, Allergic, Perennial
Interventions
DRUG

Cetirizine

Trial Locations (28)

277-0882

GSK Investigational Site, Chiba

807-0856

GSK Investigational Site, Fukuoka

811-1201

GSK Investigational Site, Fukuoka

819-0002

GSK Investigational Site, Fukuoka

001-0923

GSK Investigational Site, Hokkaido

007-0840

GSK Investigational Site, Hokkaido

053-0833

GSK Investigational Site, Hokkaido

061-1133

GSK Investigational Site, Hokkaido

061-1448

GSK Investigational Site, Hokkaido

062-0034

GSK Investigational Site, Hokkaido

212-0027

GSK Investigational Site, Kanagawa

213-0011

GSK Investigational Site, Kanagawa

216-0002

GSK Investigational Site, Kanagawa

222-0011

GSK Investigational Site, Kanagawa

224-0003

GSK Investigational Site, Kanagawa

232-0056

GSK Investigational Site, Kanagawa

862-0952

GSK Investigational Site, Kumamoto

862-0962

GSK Investigational Site, Kumamoto

870-0021

GSK Investigational Site, Ōita

333-0861

GSK Investigational Site, Saitama

336-0022

GSK Investigational Site, Saitama

350-1205

GSK Investigational Site, Saitama

355-0062

GSK Investigational Site, Saitama

420-0803

GSK Investigational Site, Shizuoka

422-8066

GSK Investigational Site, Shizuoka

436-0058

GSK Investigational Site, Shizuoka

157-0067

GSK Investigational Site, Tokyo

170-0005

GSK Investigational Site, Tokyo

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY